Next Article in Journal
Common Superficial Bacterial Skin Infections Self-Reported by 1047 Greek Competitive Swimmers: A 2021 Retrospective Study
Previous Article in Journal
Development of a PCR Assay for the Detection of Legionella micdadei in the Environment
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Distribution and Factors Associated with Neisseria gonorrhoeae Cases in Kampala, Uganda, 2016–2020

1
Infectious Diseases Institute, Makerere University, Kampala P.O. Box 22418, Uganda
2
Lifenet International, Kampala P.O. Box 23308, Uganda
3
School of Public Health, Makerere University, Kampala P.O. Box 7072, Uganda
*
Authors to whom correspondence should be addressed.
Infect. Dis. Rep. 2025, 17(5), 132; https://doi.org/10.3390/idr17050132
Submission received: 17 June 2025 / Revised: 11 August 2025 / Accepted: 20 August 2025 / Published: 17 October 2025
(This article belongs to the Section Sexually Transmitted Diseases)

Abstract

Background: Gonorrhoea is a common sexually transmitted infection with serious health consequences if not well-treated. Resistance to common therapeutic agents and limited diagnostics further heighten its burden on sexual and reproductive health. This study determined the positivity level, spatial distribution and factors influencing test positivity for Neisseria gonorrhoeae in Kampala, Uganda. Methods: Clinical data and urethral swabs were primarily collected from men with urethritis at 10 high-volume surveillance facilities. Laboratory analysis followed conventional microbiology techniques. Statistical analysis was conducted using R 4.4.3. Results: Among 1663 participants, 923 (56%, 95% CI: 53–58%) tested positive for N. gonorrhoeae, with comparable levels in Kampala divisions. Co-positivity of HIV and N. gonorrhoeae ranged from 5–27%. At bivariable analysis, there was a lower risk of testing positive for N. gonorrhoeae among participants aged above 24 years. Individuals who never use condoms or infrequently use them were marginally at a higher risk for positivity compared to routine users. Only age was the independent predictor for positivity with N. gonorrhoeae (aPR = 0.93, 95% CI: 0.87–0.99, p-value = 0.017), with men aged above 24 years being less likely to test positive for N. gonorrhoeae. Conclusions: Spatial distribution of N. gonorrhoeae positivity in Kampala was found not to be significantly influenced by location in any of the five divisions. Public health interventions should be tailored to focus on the high-risk groups such as men aged below 25 years, incorporating targeted education and prevention programs, particularly emphasizing consistent condom use among sexually active individuals to improve sexual and reproductive health in Kampala and greater Uganda.

1. Introduction

Gonorrhoea is a sexually transmitted infection (STI) caused by the bacterium Neisseria gonorrhoeae. This is primarily transmitted through vaginal, oral and anal sex [1]. The majority of gonorrhoea cases are asymptomatic, especially among women, which limits early detection and management [2,3]. Symptomatic presentation is mostly among men and these present with urethral discharge while women indicate with vaginal discharge [1,4]. Untreated gonorrhoea can cause serious complications such as pelvic inflammatory disease which in turn may result in chronic pelvic pain, infertility, an increased risk of ectopic pregnancy, and neonatal conjunctivitis, and may also increase the risk of acquiring or transmitting human immunodeficiency virus (HIV) [1,2].
In 2020, the World Health Organization estimated that there were 82.4 million Neisseria gonorrhoeae cases globally [1]. The estimated global prevalence of gonorrhoea in 2016 was 0.9% and 0.7% among women and men, respectively [5]. The prevalence appears to be higher in Sub-Saharan Africa (SSA), estimated to be 3.28% as reported among women of reproductive age [6]. A systematic review revealed up to 7.9% positivity for N. gonorrhoeae in SSA [7]. Much higher positivity levels have been reported among men with urethral discharge syndrome in Kampala, ranging from 51.1–66.4% [8,9]. Additionally, for those attending four STD clinics in and around Kampala, Uganda, the prevalence of Neisseria gonorrhoeae was 55% and 15% among men and women, respectively [10].
Significant levels of antimicrobial resistance have been reported among isolates of Neisseria gonorrhoeae against commonly used antibiotics [11,12,13]. This is in addition to the limited availability of timely diagnostic tests to guide choice of treatment antibiotics, especially in low- and middle-income countries (LMICs) [3,13]. These factors have jointly exacerbated the impact of gonorrhoea on global sexual and reproductive health.
Efforts have previously been employed to reduce this burden through the Global Health Sector Strategy on sexually transmitted infections, 2016–2021 [14]. Effective STI control is dependent on understanding their distribution in populations [15]. There is limited data about the distribution and influencers of N. gonorrhoeae disaggregated by location in Uganda. Understanding this epidemiology is crucial to identify the most affected areas, most at-risk populations and possible risk factors. This facilitates the optimum allocation of scarce resources to design and implement cost-effective disease control and surveillance strategies. This will contribute to the reduction of the burden in communities in line with the global strategies against STIs, contributing to the achievement of the goals for sustainable development [16]. This study determined the positivity levels and factors associated with a positive test for Neisseria gonorrhoeae in the five divisions of Kampala, Uganda.

2. Materials and Methods

2.1. Study Design and Settings

A cross-sectional study design was used. This was a secondary analysis of N. gonorrhoeae surveillance data from the Enhanced Gonococcal Antimicrobial Surveillance Program (EGASP) in Uganda. The data collection was conducted between September 2016 to September 2020 in the 10 identified high-volume facilities. They are located within the capital city, Kampala in central Uganda. These included China-Uganda Friendship Hospital (Naguru), Most at Risk Populations Initiative (MARPI) clinic, Murchison Bay Hospital, Luzira Prison Health Centre (HC) IV, Luzira Upper Prison HC III, Infectious Diseases Institute (IDI) Clinic, Kampala Remand Prison HC III, Kiruddu General Hospital, Kawaala HC III and Kisenyi HC IV.

2.2. Study Population

This study was based on surveillance among men presenting with urethritis at the 10 healthcare facilities.

2.3. Data Collection and Laboratory Procedures

The detailed sample management and analysis methods have been previously described [17]. In brief, standardized procedures were utilized across sites and only men with urethral discharge syndrome attending these sentinel clinics were considered. Various demographic and socio-sexual details were captured from the participants, and urethral swabs were collected. Positive N. gonorrhoeae cases were identified using a combination of laboratory test outcomes including Gram stain test and bacterial culture. Detection of Gram-negative intracellular diplococci in primary urethral samples was the minimum requirement to identify a positive case. This was followed up with a microbiology culture test where small translucent colonies on gonococcal-specific media called modified Thayer–Martin agar and chocolate agar incubated between 35–36.5 °C in 5% carbon dioxide were used to characterize positive cases for N. gonorrhoeae. Isolated organisms were further identified using a combination of a positive oxidase test and sugar fermentation outcomes alongside known standard organisms for quality control.

2.4. Statistical Analysis

Poisson regression with robust variance was done using R 4.4.3 (R Foundation for Statistical Computing, Vienna, Austria) to identify factors associated with N. gonorrhoeae positivity. Multicollinearity was assessed and ruled out, then bivariable analysis was conducted for all independent variables at the 20% level. All variables with a p-value ≤ 0.2 were considered for multivariable analysis following the backward stepwise elimination approach. Predictors with p-value < 0.05 were regarded to have a statistically significant association with N. gonorrhoeae positivity.

3. Results

We enrolled 1663 participants within the Greater Kampala Metropolitan Area (GKMA) specifically residing in the five (5) divisions that make up Kampala, including Makindye, Rubaga, Central, Kawempe and Nakawa division. The median age of the study participants was 25 (IQR = 22–30). The median number of sexual partners for the study participants was 2 (IQR = 1–2). Of the 109 people with HIV presenting with urethral symptoms, 55 (50%) were found to have gonorrhoea co-infection. The positivity rates were highest at Kisenyi HC IV at 68% (n = 282), followed by Naguru hospital at 57% (n = 203) (Table 1).

3.1. Positivity Levels of N. gonorrhoeae in Kampala

The overall positivity of N. gonorrhoeae based on the Gram stain test in the surveyed population (n = 1663) was 73%, 95% CI (71–75%) while the bacterial culture test positivity was 56% (923/1663). The Nakawa division had the majority of positive N. gonorrhoeae cases at 291 (31.5%) while Central had the least at 75 (8.1%) (Table 2).
Among participants with HIV, the Rubaga division, at 27% (15/55), showed the highest positivity rates while the Central division had the least (Figure 1).
The positivity of N. gonorrhoeae among participants with more than one sexual partner was greater in Nakawa division, at 30% (139/469) followed by Rubaga (Figure 2).

3.2. Risk Factors for Testing Positive with N. gonorrhoeae

At bivariable analysis, participants with age greater than 24 were at lower risk of positivity for N. gonorrhoeae. Participants who never use condoms and those who use them infrequently were more likely to have a positive test for N. gonorrhoeae compared to those who always use condoms (Table 3). There was no significant association between a history of exchange of sex for money, number of sex partners, HIV status and N. gonorrhoeae positivity. After adjustment for confounders, only age was the statistically significant factor associated with N. gonorrhoeae positivity.

4. Discussion

Understanding the geographical distribution and influencing factors for STIs is critical for their proper management to lighten the burden imposed on sexual and reproductive health. In this secondary analysis of an urban surveillance cohort of males with urethritis, we found comparable positivity levels across the five divisions of Kampala. The overall positivity of gonorrhoea was as high as 56% among all patients presenting at STI clinics and other facilities in the Kampala surveillance program for N. gonorrhoeae and is similar to 66.4% observed in the earlier study [9]. The positivity based on Gram stain test was greater than the observed organism recovery from bacterial culture. This could be due to the fragile nature of the target organism whose isolation from urethral samples could be affected by various factors including prior antibiotic use, delayed processing after sample collection, and fastidious culture requirements leading to lower positivity. The overall observed level of positivity is greater than levels reported earlier within Uganda and elsewhere [10,18,19]. This could be due to the difference in the social-spatial predisposing factors in these areas, with more in Kampala explaining the observed positivity.
The Nakawa division had over 31 cases per 100 participants tested by culture which was slightly higher than other divisions. This could be due to more men having more than one sexual partner than other divisions. Individuals with more than one sexual partner have been previously associated with a higher risk of infection [20]. It could also be because this division houses multiple people outside the city business center including sex workers, and university students who are more likely to engage in high-risk sexual practices that can increase infection transmission. However, the differences in positivity within the five divisions was not statistically significant.
At bivariable analysis, there was reduced risk for N. gonorrhoeae positivity among men with age greater than 24 years, and occasional condom use, although the latter was not found to be an independent predictor. However, this association has been reported elsewhere [19]. Condom use has also been a previously known protective factor against STIs [19,21,22]. At multivariable analysis, only age was the independent predictor for N. gonorrhoeae infection where those aged greater than 24 years were less likely to test positive. Other studies have also found a younger age (18–25 years) to be more associated with gonorrhoea infection [9,23,24]. This could be due to this being the most sexually active age group increasing their susceptibility to sexually transmitted infections [25,26]. Additionally, it would be expected that individuals who engage in unprotected sex or have multiple sexual partners are at a higher risk of contracting gonorrhoea despite not being a statistically significant association in this scenario. This could be a type II error due to the possibility of limited statistical power to detect this association.

5. Limitations

The study was limited by several factors including the target population of only males presenting with urethral discharge syndrome. Despite being ambiguous, female cases could refine the picture of the disease in this urban area. Advanced biochemical and molecular testing could have facilitated higher case detection and confirmation of N. gonorrhoeae and related Neisseria species. In addition, the data on HIV status were collected by self-report and over 19% of the men were not aware of, or did not report their HIV status. The clinical outcome data, and the nature of antibiotic treatment taken prior to clinic attendance, were unknown. Similarly, geographic information system (GIS) data were not obtained to enable location mapping of cases observed.
Since sexual orientation was not included in the model, there is a possibility that the spatial effect accounted for by areas with large populations of men who have sex with men (MSM) and associated social-sexual networks were not controlled for. In addition, we did not capture asymptomatic cases which could account for up to 10% in men. Selection bias was noted as data were collected from specific populations of clinic attendees who were not fully representative of the general population, also compounded by other limitations associated with surveillance level data.

6. Conclusions

This study observed no significant variations in the positivity of Neisseria gonorrhoeae across the five divisions of Kampala, Uganda. The findings show a high overall positivity of 56% among men attending study clinics. Public health strategies can be tailored to focus on high-risk groups such as those aged below 25 years, incorporating targeted education and prevention programs, particularly emphasizing a single sexual partner and consistent use of condoms.
Future studies should investigate the underlying social-spatial factors contributing to the high prevalence of STIs in Kampala. There is a need for research exploring the mechanisms driving the higher susceptibility to infection in specific populations, such as university students, couples, MSMs and other sexual networks. These studies should also consider potential biases in self-reported data, asymptomatic N. gonorrhoeae, and aim to develop more accurate assessment methods. Understanding these factors will be crucial for enhancing public health strategies and improving sexual and reproductive health outcomes in the region.

Author Contributions

Conceptualization, F.K., R.K. and A.K.; methodology, F.L., C.T., R.K., P.E., H.M., D.M.B., A.K. and F.K.; validation, R.K., D.M.B., A.K. and F.K.; formal analysis, P.E., F.L., and R.K.; investigation, F.L., C.T., P.E. and R.K.; resources, A.K. and F.K.; data curation, F.L., C.T., P.E. and R.K.; writing—original draft preparation, F.L., C.T., and R.K.; writing—review and editing, F.L., C.T., R.K., P.E., H.M., D.M.B., A.K. and F.K.; visualization, P.E.; supervision, A.K. and F.K.; funding acquisition, A.K. and F.K. All authors have read and agreed to the published version of the manuscript.

Funding

This researcher is affiliated with the Wellcome Trust CAMO-Net programme [grant ref: 226692/Z/22/Z].

Institutional Review Board Statement

This was a secondary analysis of N. gonorrhoeae surveillance data within the gonococcal surveillance program that was approved by the Ugandan Ministry of Health and performed as part of public health surveillance activities. It was not actual research and thus did not require any further approval from a research ethics committee.

Informed Consent Statement

There was no need to obtain informed consent from individuals since they were not directly engaged in this study.

Data Availability Statement

The data presented in this study are available on request from the corresponding author. The raw data supporting the conclusions of this article will be made available by the authors on request.

Conflicts of Interest

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Abbreviations

The following abbreviations are used in this manuscript:
NGNeisseria gonorrhoeae
HIVHuman Immunodeficiency Virus
STDSexually Transmitted Disease
STISexually Transmitted Infection

References

  1. World Health Organization. Sexually Transmitted Infections (STIs) Geneva: World Health Organization. 2023. Available online: https://www.who.int/news-room/fact-sheets/detail/sexually-transmitted-infections-(stis) (accessed on 27 April 2024).
  2. Chidiac, O.; AlMukdad, S.; Harfouche, M.; Harding-Esch, E.; Abu-Raddad, L.J. Epidemiology of gonorrhoea: Systematic review, meta-analyses, and meta-regressions, World Health Organization European Region, 1949 to 2021. Eurosurveillance 2024, 29, 2300226. [Google Scholar] [CrossRef]
  3. Iwuji, C.; Pillay, D.; Shamu, P.; Murire, M.; Nzenze, S.; Cox, L.A.; Mullick, S. A systematic review of antimicrobial resistance in Neisseria gonorrhoeae and Mycoplasma genitalium in sub-Saharan Africa. J. Antimicrob. Chemother. 2022, 77, 2074–2093. [Google Scholar] [CrossRef]
  4. Martín-Sánchez, M.; Ong, J.J.; Fairley, C.K.; Chen, M.Y.; Williamson, D.A.; Maddaford, K.; Aung, E.T.; Carter, G.; Bradshaw, C.S.; Chow, E.P.F. Clinical presentation of asymptomatic and symptomatic heterosexual men who tested positive for urethral gonorrhoea at a sexual health clinic in Melbourne, Australia. BMC Infect. Dis. 2020, 20, 486. [Google Scholar] [CrossRef]
  5. Rowley, J.; Vander Hoorn, S.; Korenromp, E.; Low, N.; Unemo, M.; Abu-Raddad, L.J.; Chico, R.M.; Smolak, A.; Newman, L.; Gottlieb, S. Chlamydia, gonorrhoea, trichomoniasis and syphilis: Global prevalence and incidence estimates, 2016. Bull. World Health Organ. 2019, 97, 548. [Google Scholar] [CrossRef]
  6. Kassa, Z.Y.; Hussen, S.; Hadra, N.; Moges, Y.; Bonja, F. Prevalence of Neisseria gonorrhoeae infection among women of reproductive age in sub-Saharan Africa: A systematic review and meta-analysis. Eur. J. Contracept. Reprod. Health Care 2020, 25, 365–371. [Google Scholar] [CrossRef] [PubMed]
  7. Longe, B.T.; Moses, O.; David, R.T.O. Neisseria gonorrhoaea Infections in Africa-Systemat-ic Review and Meta-Analysis. J. Microbiol. Antimicrob. Agents 2020, 5, 4–9. [Google Scholar]
  8. Kakooza, F.; Musinguzi, P.; Workneh, M.; Walwema, R.; Kyambadde, P.; Mande, E.; Lubega, C.; Nakasi, J.M.; Kiggundu, R.; Hamill, M.M. Implementation of a standardised and quality-assured enhanced gonococcal antimicrobial surveillance programme in accordance with WHO protocols in Kampala, Uganda. Sex. Transm. Infect. 2021, 97, 312–316. [Google Scholar] [CrossRef] [PubMed]
  9. Hamill, M.M.; Onzia, A.; Wang, T.-H.; Kiragga, A.N.; Hsieh, Y.-H.; Parkes-Ratanshi, R.; Gough, E.; Kyambadde, P.; Melendez, J.H.; Manabe, Y.C. High burden of untreated syphilis, drug resistant Neisseria gonorrhoeae, and other sexually transmitted infections in men with urethral discharge syndrome in Kampala, Uganda. BMC Infect. Dis. 2022, 22, 440. [Google Scholar] [CrossRef] [PubMed]
  10. Nakku-Joloba, E.; Mboowa, G.; Ssengooba, W.; Kiyimba, A.; Kigozi, E.; Baluku, H.; Alinaitwe, L.; Nyote, R.; Kabahita, J.M.; Mutumba, P.; et al. Prevalence and antimicrobial resistance profiles of Neisseria gonorrhea and Chlamydia trachomatis isolated from individuals attending STD clinics in Kampala, Uganda. Afr. Health Sci. 2022, 22, 62–71. [Google Scholar] [CrossRef]
  11. Kakooza, F.; Kiggundu, R.; Mboowa, G.; Kateete, P.D.; Nsangi, O.T.; Kabahita, J.M.; Ssentalo Bagaya, B.; Golparian, D.; Unemo, M. Antimicrobial susceptibility surveillance and antimicrobial resistance in Neisseria gonorrhoeae in Africa from 2001 to 2020: A mini-review. Front. Microbiol. 2023, 14, 1148817. [Google Scholar] [CrossRef]
  12. Unemo, M.; Lahra, M.M.; Escher, M.; Eremin, S.; Cole, M.J.; Galarza, P.; Ndowa, F.; Martin, I.; Dillon, J.-A.R.; Galas, M. WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017–18: A retrospective observational study. Lancet Microbe 2021, 2, e627–e636. [Google Scholar] [CrossRef]
  13. World Health Organization. Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP): General Protocol. Geneva: World Health Organization. 2021. Available online: https://www.who.int/publications/i/item/9789240021341 (accessed on 27 April 2024).
  14. World Health Organization. Global Health Sector Strategy on Sexually Transmitted Infections, 2016–2021 Geneva: World Health Organization. 2016. Available online: https://www.who.int/publications/i/item/WHO-RHR-16.09 (accessed on 27 April 2024).
  15. Francis, S.C.; Mthiyane, T.N.; Baisley, K.; McHunu, S.L.; Ferguson, J.B.; Smit, T.; Crucitti, T.; Gareta, D.; Dlamini, S.; Mutevedzi, T.; et al. Prevalence of sexually transmitted infections among young people in South Africa: A nested survey in a health and demographic surveillance site. PLoS Med. 2018, 15, e1002512. [Google Scholar] [CrossRef]
  16. World Health Organization. Global Health Sector Strategies on, Respectively, HIV, Viral Hepatitis and Sexually Transmitted Infections for the Period 2022–2030. Geneva: World Health Organization. 2022. Available online: https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/strategies/global-health-sector-strategies (accessed on 27 April 2024).
  17. Workneh, M.; Hamill, M.M.; Kakooza, F.; Mande, E.; Wagner, J.; Mbabazi, O.; Mugasha, R.; Kajumbula, H.; Walwema, R.; Zenilman, J.; et al. Antimicrobial Resistance of Neisseria Gonorrhoeae in a Newly Implemented Surveillance Program in Uganda: Surveillance Report. JMIR Public Health Surveill. 2020, 6, e17009. [Google Scholar] [CrossRef] [PubMed]
  18. Kiyingi, J.; Nabunya, P.; Bahar, O.S.; Mayo-Wilson, L.J.; Tozan, Y.; Nabayinda, J.; Namuwonge, F.; Nsubuga, E.; Kizito, S.; Nattabi, J.; et al. Prevalence and predictors of HIV and sexually transmitted infections among vulnerable women engaged in sex work: Findings from the Kyaterekera Project in Southern Uganda. PLoS ONE 2022, 17, e0273238. [Google Scholar] [CrossRef] [PubMed]
  19. McHaro, R.D.; Kisinda, A.; Njovu, L.; McHaro, M.; Mbwilo, F.; Mihale, G.; Komba, B.; Andrew, E.; Mayaud, P.; Kroidl, A.; et al. Prevalence of and risk factors associated with HIV, Herpes Simplex Virus-type 2, Chlamydia trachomatis and Neisseria gonorrhoeae infections among 18–24 year old students attending Higher Learning Institutions in Mbeya-Tanzania. PLoS ONE 2022, 17, e0266596. [Google Scholar] [CrossRef] [PubMed]
  20. Siziba, A.; Nunu, W.N.; Mudonhi, N.; Ndlovu, V.; Munyai, O.; Ndlovu, B.; Sanganyado, E. Risk factors associated with a high incidence of sexually transmitted infections in Beitbridge, Zimbabwe. Curationis 2022, 45, e1–e5. [Google Scholar] [CrossRef]
  21. Ayoub, H.H.; Tomy, M.; Chemaitelly, H.; Omori, R.; Buse, K.; Low, N.; Hawkes, S.; Abu-Raddad, L.J. Dynamics of Neisseria gonorrhoeae transmission among female sex workers and clients: A mathematical modeling study. Epidemics 2024, 48, 100785. [Google Scholar] [CrossRef]
  22. World Health Organization. Gonorrhoea (Neisseria Gonorrhoeae Infection) 10 August 2024. Available online: https://www.who.int/news-room/fact-sheets/detail/gonorrhoea-(neisseria-gonorrhoeae-infection)#:~:text=Most%20cases%20of%20gonorrhoea%20can%20be%20prevented%20with%20consistent%20and,the%20spread%20of%20the%20disease (accessed on 10 August 2024).
  23. Peace, N.; Elliot, A.; Lawrence, N.; Felix, T.; Apecu, R.O. Prevalence and antimicrobial susceptibility patterns of Neisseria gonorrhea among the symptomatic patients attending outpatient department in Lyatonde District Hospital Southwestern Uganda. Int. J. Sci. Rep. 2019, 5. [Google Scholar] [CrossRef]
  24. Mabonga, E.; Manabe, Y.C.; Elbireer, A.; Mbazira, J.K.; Nabaggala, M.S.; Kiragga, A.; Kisakye, J.; Gaydos, C.A.; Taylor, C.; Parkes-Ratanshi, R. Prevalence and predictors of asymptomatic Chlamydia trachomatis and Neisseria gonorrhoeae in a Ugandan population most at risk of HIV transmission. Int. J. STD AIDS 2021, 32, 510–516. [Google Scholar] [CrossRef]
  25. Sahile, A.; Teshager, L.; Fekadie, M.; Gashaw, M. Prevalence and Antimicrobial Susceptibility Patterns of Neisseria gonorrhoeae among Suspected Patients Attending Private Clinics in Jimma, Ethiopia. Int. J. Microbiol. 2020, 2020, 7672024. [Google Scholar]
  26. Ssekamatte, T.; Nalugya, A.; Mugambe, R.K.; Wagaba, B.; Nakalembe, D.; Mutebi, A.; Bagonza, R.A.; Tigaiza, A.; Kansiime, W.K.; Ssempala, R.; et al. Prevalence and predictors of sex under the influence of psychoactive substances among young people in informal settlements in Kampala, Uganda. BMC Public Health 2023, 23, 801. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Positivity of N. gonorrhoeae among HIV clients in the divisions of Kampala. NG—N. gonorrhoeae. Co-positivity of HIV and NG was up to 55 cases.
Figure 1. Positivity of N. gonorrhoeae among HIV clients in the divisions of Kampala. NG—N. gonorrhoeae. Co-positivity of HIV and NG was up to 55 cases.
Idr 17 00132 g001
Figure 2. Positivity of N. gonorrhoeae among those with more than one sexual partner in Kampala. NG—N. gonorrhoeae. Up to 469 cases had more than one sexual partner.
Figure 2. Positivity of N. gonorrhoeae among those with more than one sexual partner in Kampala. NG—N. gonorrhoeae. Up to 469 cases had more than one sexual partner.
Idr 17 00132 g002
Table 1. Demographic characteristics of the study participants.
Table 1. Demographic characteristics of the study participants.
CharacteristicPositive for
N. gonorrhoeae
(Gram Staining)
n = 1218
Positive for
N. gonorrhoeae
(Gram Staining and Culture)
n = 923
HIV Status
  Negative874 (71.8%) *658 (71.2%)
  Positive78 (6.4%)55 (5.9%)
  Unknown266 (21.8%)210 (22.7%)
Age group
Median (IQR) age24 (21, 30) **
  ≤24 years610 (50.0%)476 (51.6%)
  Greater than 24 years580 (47.6%)425 (46.0%)
  Unknown28 (2.3%)22 (2.4%)
Number of Sex partners in the last six months
Median (IQR) no. of sexual partners 2.00 (1.00, 2.00)
  ≤1 Partner553 (45.4%)412 (44.6%)
  >1 Partner595 (48.8%)469 (50.8%)
  Unknown70 (5.7%)42 (4.6%)
Condom Use
  Always10 (0.8%)8 (0.8%)
  Never463 (38.0%)336 (36.4%)
  Sometimes722 (59.3%)565 (61.2%)
  Unknown23 (1.9%)14 (1.5%)
Facility Name
  IDI Clinic11 (0.9%)9 (0.9%)
  Kampala Remand Prison HC III43 (3.5%)26 (2.8%)
  Kawaala HC III189 (15.5%)147 (15.9%)
  Kirruddu GH150 (12.3%)115 (12.5%)
  Kisenyi HC IV332 (27.3%)282 (30.6%)
  Luzira Prison HC IV79 (6.5%)48 (5.2%)
  Luzira Upper Prison HC III20 (1.6%)3 (0.3%)
  MARPI Mulago90 (7.4%)77 (8.3%)
  Murchison Bay hospital37 (3.0%)13 (1.4%)
  Naguru hospital267 (21.9%)203 (22.0%)
History of Sex exchange for Money167 (13.7%)128 (13.9%)
Urethral discharge1185 (97.2%)916 (99.2%)
Dysuria1082 (88.8%)822 (89.1%)
* Percentage positivity per variable, ** Interquartile range (IQR).
Table 2. Positivity of N. gonorrhoeae within the divisions of Kampala.
Table 2. Positivity of N. gonorrhoeae within the divisions of Kampala.
CharacteristicOverall
n = 1663 (95% CI 1)
Central
n = 113
(95% CI)
Kawempe
n = 218
(95% CI)
Makindye
n = 340
(95% CI)
Nakawa
n = 579
(95% CI)
Rubaga
n = 413
(95% CI)
Positivity
(Gram stain)
1218 (73%)
(71%, 75%) 1
91 (7.5%)
(6.1%, 9.1%)
155 (12.7%)
(11%, 15%)
244 (20%)
(18%, 22%)
409 (33.5%)
(31%, 36%)
319 (26.4%)
(24%, 29%)
Positivity
(Gram stain & Culture)
923 (56%)
(53%, 58%)
75 (8.1%)
(6.5%, 10%)
113 (12.2%)
(10%, 15%)
185 (20.0%)
(18%, 623%)
291 (31.5%)
(29%, 35%)
259 (28.1%)
(25%, 31%)
CI 1 = Confidence Interval.
Table 3. Results from the Bivariable and Multivariable analysis.
Table 3. Results from the Bivariable and Multivariable analysis.
CharacteristicBivariable Analysis
(cPR 1 (95% CI 2))
p-ValueMultivariable Analysis (aPR 3 (95%CI))p-Value
  Patient Age group
≤24 years1 1
Greater than 24 years0.93 (0.88, 0.99) 20.02 *0.93 (0.87, 0.99)0.017 **
  HIV Status
Negative1
Positive0.98 (0.87, 0.75)0.79
Unknown1.04 (0.96, 1.14)0.27
  Number of sex partners in the last 6 months
≤1 Partner1
>1 Partner0.99 (0.93, 1.05)0.82
  Condom Use
Always1 1
Never1.44 (0.90, 2.29)0.12 *1.43 (0.89, 2.30)0.141
Sometimes1.48 (0.93, 2.36)0.09 *1.47 (0.93, 2.36)0.115
  History of Sex Money Exchange
No1
Yes0.96 (0.88, 1.06)0.48
  Division
Central1 1
Kawempe0.88 (0.77, 1.01)0.08 *0.90 (0.79, 1.03)0.145
Makindye0.90 (0.80, 1.02)0.13 *0.91 (0.81, 1.03)0.169
Nakawa0.89 (1.00, 0.07)0.07 *0.90 (0.80, 1.01)0.07
Rubaga0.98 (0.88, 1.11)0.840.99 (0.88, 1.11)0.89
cPR 1 = Crude Prevalence Ratios, aPR 3 = adjusted Prevalence Ratios; CI 2 = Confidence Interval, * = Statistically Significant at p < 0.2; ** = Statistically Significant at p < 0.05.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Lwigale, F.; Tumwine, C.; Kiggundu, R.; Elungat, P.; Mackline, H.; Byonanebye, D.M.; Kambugu, A.; Kakooza, F. Distribution and Factors Associated with Neisseria gonorrhoeae Cases in Kampala, Uganda, 2016–2020. Infect. Dis. Rep. 2025, 17, 132. https://doi.org/10.3390/idr17050132

AMA Style

Lwigale F, Tumwine C, Kiggundu R, Elungat P, Mackline H, Byonanebye DM, Kambugu A, Kakooza F. Distribution and Factors Associated with Neisseria gonorrhoeae Cases in Kampala, Uganda, 2016–2020. Infectious Disease Reports. 2025; 17(5):132. https://doi.org/10.3390/idr17050132

Chicago/Turabian Style

Lwigale, Fahad, Conrad Tumwine, Reuben Kiggundu, Patrick Elungat, Hope Mackline, Dathan M. Byonanebye, Andrew Kambugu, and Francis Kakooza. 2025. "Distribution and Factors Associated with Neisseria gonorrhoeae Cases in Kampala, Uganda, 2016–2020" Infectious Disease Reports 17, no. 5: 132. https://doi.org/10.3390/idr17050132

APA Style

Lwigale, F., Tumwine, C., Kiggundu, R., Elungat, P., Mackline, H., Byonanebye, D. M., Kambugu, A., & Kakooza, F. (2025). Distribution and Factors Associated with Neisseria gonorrhoeae Cases in Kampala, Uganda, 2016–2020. Infectious Disease Reports, 17(5), 132. https://doi.org/10.3390/idr17050132

Article Metrics

Back to TopTop